Resolution of inflammation: State of the art, definitions and terms

FASEB Journal

Volumn 21, Issue 2, 2007, Pages 325-332

  Serhan, Charles N ^a   Brain, Sue D ^b   Buckley, Christopher D ^c   Gilroy, Derek W ^d   Haslett, Christopher ^e   O'Neill, Luke A J ^f   Perretti, Mauro ^g   Rossi, Adriano G ^e   Wallace, John L ^h  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f TRINITY COLLEGE DUBLIN   (Ireland)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^h UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anti inflammatories; Chemokines; Cytokines; Leukocytes; Lipid mediators

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ACETYLSALICYLIC ACID; ANNEXIN; ANTIINFLAMMATORY AGENT; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; GLUCOCORTICOID; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; LIPOXIN; METHOTREXATE; NOD LIKE RECEPTOR; RECEPTOR; SALAZOSULFAPYRIDINE; TACROLIMUS; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG; WORTMANNIN;

ANTIINFLAMMATORY ACTIVITY; CELL FUNCTION; DRUG MECHANISM; ENDOTHELIUM CELL; EOSINOPHIL; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; INFECTION; INFLAMMATION; INFLAMMATORY DISEASE; INJURY; LEUKOCYTE; MACROPHAGE; MEDIATOR RELEASE; MONOCYTE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PLEURISY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; REVIEW; TISSUE REPAIR;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CYTOKINES; HUMANS; INFLAMMATION; LEUKOCYTES; MODELS, BIOLOGICAL;

EID: 33846823024     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-7227rev     Document Type: Review

References (32)

1. Cotran, R. S., Kumar, V., and Collins, T., eds. (1999) Robbins Pathologic Basis of Disease, W.B. Saunders Co., Philadelphia, Pennsylvania, USA
2. Filer, A., Pitzalis, C., and Buckley, C. D. (2006) Targeting the stromal microenvironment in chronic inflammation. Curr. Opin. Pharmacol. 6, 393-400
3. Serhan, C. N. (2004) A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochem. Cell Biol. 122, 305-321
4. Gilroy, D. W., Lawrence, T., Perretti, M., and Rossi, A. G. (2004) Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug. Discov. 3, 401-416
5. Perretti, M. (1997) Endogenous mediators that inhibit the leukocyte-endothelium interaction. Trends Pharmacol. Sci. 18, 418-425
6. Weissmann, G., Smolen, J. E., and Korchak, H. M. (1980) Release of inflammatory mediators from stimulated neutrophils. N. Engl. J. Med. 303, 27-34
7. Majno, G., and Joris, I. (2004) Cells, Tissues, and Disease: Principles of General Pathology, Oxford Univ. Press, New York, New York, USA
8. Bannenberg, G. L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K. H., Hong, S., and Serhan, C. N. (2005) Molecular circuits of resolution: Formation and actions of resolvins and protectins. J. Immunol. 174, 4345-4355
9. Damazo, A. S., Yona, S., Flower, R. J., Perretti, M., and Oliani, S. M. (2006) Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis. J. Immunol. 176, 4410-4418
10. Parsonage, G., Filer, A. D., Haworth, O., Nash, G. B., Rainger, G. E., Salmon, M., and Buckley, C. D. (2005) A stromal address code defined by fibroblasts. Trends. Immunol. 26, 150-156
11. Creagh, E., and O'Neill, L. A. (2006) TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 352-357
12. Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., and Tschopp, J. (2004) NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20, 319-325
13. Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., et al. (2005) Regulation of lung injury and repair by toll-like receptors and hyaluronan. Nature Med. 11, 1173-1179
14. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A., and Tschopp, J. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241
15. Shi, Y., Evans, J. E., and Rock, K. L. (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425, 516-521
16. Liew, F. Y., Xu, D., Brint, E. K., and O'Neill, L. A. (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5, 446-458
17. Sonya, M. A., et al. (2006) Anti-inflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatise-1 (DUSP1). J. Exp. Med., in press
18. Liu, H., Komai-Koma, M., Xu, D., and Liew, F. Y. (2006) Toll-like receptor 2 signalling modulates the functions of CD4+ CD25+ regulatory T cells. Proc. Natl. Acad. Sci. U. S. A. 103, 7048-7053
19. Sutmuller, R. P., den Brok, M. H., Kramer, M., Bennink, E. J., Toonen, L. W., Kullberg, B. J., Joosten, L. A., Akira, S., Netea, M. G., and Adema, G. J. (2006) Toll-like receptor-2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116, 485-494
20. Buckley, C. D., Pilling, D., Lord, J. M., Akbar, A. N., Scheel-Toellner, D., and Salmon, M. (2001) Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends. Immunol. 22, 199-204
21. Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., and Willoughby, D. A. (1999) Inducible cycloxygenase may have anti-inflammatory properties. Nature Med. 5, 698-701
22. Liu, Y., Cousin, J. M., Hughes, J., Van Damme, J., Seckl, J. R., Haslett, C., Dransfield, I., Savill, J., and Rossi, A. G. (1999) Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J. Immunol. 162, 3639-3646
23. Giles, K. M., Ross, K., Rossi, A. G., Hotchin, N. A., Haslett, C., and Dransfield, I. (2001) Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active Rac. J. Immunol. 167, 976-986
24. Maderna, P., Yona, S., Perretti, M., and Godson, C. (2005) Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26). J. Immunol. 174, 3727-3733
25. Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., and Moussignac, R.-L. (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025-1037
26. Serhan, C. N., and Savill, J. (2005) Resolution of inflammation: the beginning programs the end. Nature Immunol. 6, 1191-1197
27. Perretti, M., Chiang, N., La, M., Fierro, I. M., Marullo, S., Getting, S. J., Solito, E., and Serhan, C. N. (2002) Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A(4) receptor. Nat. Med. 8, 1296-1302
28. Sawatzky, D. A., Willoughby, D. A., Colville-Nash, P. R., and Rossi, A. G. (2006) The involvement of the apoptosis-modulating proteins ERK 1/2, Bcl-xL and Bax in the resolution of acute inflammation in vivo. Am. J. Pathol. 168, 33-41
29. Pinho, V., Souza, D. G., Barsante, M. M., Hamer, F. P., De Freitas, M. S., Rossi, A. G., and Teixeira, M. M. (2005) Phosphoinositide-3 kinases critically regulate the recruitment and survival of eosinophils in vivo: importance for the resolution of allergic inflammation. J. Leukoc. Biol. 77, 800-810
30. Cronstein, B. N. (2006) Going with the flow: methotrexate, adenosine, and blood flow. Ann. Rheum. Dis. 65, 421-422
31. Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., and Serhan, C. N. (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nature. Immunol. 2, 612-619
32. Rossi, A. G., Sawatzky, D. A., Walker, A., Ward, C., Sheldrake, T. A., Riley, N. A., Caldicott, A., Martinez-Losa, M., Walker, T. R., Duffin, R., et al. (2006) Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat. Med. 12, 1056-1064